KVUE•November 20, 2026 at 3:00 PM UTCHousehold & Personal Products

Kenvue Acquisition Closes: Merger-Arb Thesis Resolved, Now Evaluate K-C Integration

Read source article

What happened

Kimberly-Clark finalized its acquisition of Kenvue on November 2, 2026, completing the transaction that had been pending since the November 2025 merger agreement. The closing occurred on the outside date, indicating that all regulatory conditions, including foreign approvals, were satisfied without fatal remedies. Kimberly-Clark reiterated its expectation of $2.1 billion in total cost savings and revenue gains over several years, consistent with prior synergy guidance. This event eliminates the merger-arbitrage spread and deal-risk discount that had been embedded in KVUE's share price, as KVUE shareholders receive 0.14625 shares of K-C plus $3.50 cash per share. KVUE is now delisted, and former holders must evaluate the combined company's fundamentals and integration prospects.

Implication

The merger-arb trade is over; there is no spread left to capture, and the $1.136B termination fee is no longer relevant. The combined entity's near-term earnings may be pressured by integration costs and the assumption of Kenvue's $8.5B debt. The $2.1B synergy target is reiterated but requires disciplined execution with a 40/40/20 ramp over three years; failure would undermine the deal's value creation. Former KVUE shareholders should re-underwrite K-C based on its pro forma valuation, leverage profile, and potential resurfacing of acetaminophen litigation or regulatory overhangs. A cautious stance is warranted until there is visible evidence that synergies are being realized and integration is proceeding smoothly.

Thesis delta

The original merger-arb thesis on KVUE expired with the deal's close; the stock no longer trades, and holders are now K-C shareholders. The investment case now hinges on Kimberly-Clark's ability to deliver the promised $2.1B synergies and manage integration complexities, rather than deal-risk assessment. This shifts the analysis from arbitrage to post-merger operational execution and valuation of the combined entity.

Confidence

high